Cargando…

Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)

Withania somnifera is a traditional Indian herb described under the ‘Rasayana’ class in Ayurveda, which gained immense popularity as a dietary supplement in the USA, Europe, Asia, and the Indian domestic market. Despite enormous research on the pharmacological effect of withanosides and withanolides...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Siddharth J., Tiwari, Anshuly, Ghule, Chetana, Pawar, Sandeep, Saste, Ganesh, Jagtap, Shubham, Singh, Ruchi, Deshmukh, Amol, Girme, Aboli, Hingorani, Lal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912008/
https://www.ncbi.nlm.nih.gov/pubmed/35268576
http://dx.doi.org/10.3390/molecules27051476
_version_ 1784666992905551872
author Modi, Siddharth J.
Tiwari, Anshuly
Ghule, Chetana
Pawar, Sandeep
Saste, Ganesh
Jagtap, Shubham
Singh, Ruchi
Deshmukh, Amol
Girme, Aboli
Hingorani, Lal
author_facet Modi, Siddharth J.
Tiwari, Anshuly
Ghule, Chetana
Pawar, Sandeep
Saste, Ganesh
Jagtap, Shubham
Singh, Ruchi
Deshmukh, Amol
Girme, Aboli
Hingorani, Lal
author_sort Modi, Siddharth J.
collection PubMed
description Withania somnifera is a traditional Indian herb described under the ‘Rasayana’ class in Ayurveda, which gained immense popularity as a dietary supplement in the USA, Europe, Asia, and the Indian domestic market. Despite enormous research on the pharmacological effect of withanosides and withanolides, bioanalytical method development and pharmacokinetics remained challenging and unexplored for these constituents due to isomeric and isobaric characteristics. In current research work, molecular descriptors, pharmacokinetic, and toxicity prediction (ADMET) of these constituents were performed using Molinspiration and admetSAR tools. A rapid, selective, and reproducible bioanalytical method was developed and validated for seven withanosides and withanolides as per USFDA/EMA guidelines, further applied to determine pharmacokinetic parameters of Withania somnifera root extract (WSE) constituents in male Sprague Dawley rats at a dose of 500 mg/kg. Additionally, an ex vivo permeability study was carried out to explore the absorption pattern of withanosides and withanolides from the intestinal lumen. In silico, ADMET revealed oral bioavailability of withanosides and withanolides following Lipinski’s rules of five with significant absorption from the gastrointestinal tract and the ability to cross the blood-brain barrier. Upon oral administration of WSE, C(max) was found to be 13.833 ± 3.727, 124.415 ± 64.932, 57.536 ± 7.523, and 7.283 ± 3.341 ng/mL for withanoside IV, withaferin A, 12-Deoxy-withastramonolide, and withanolide A, respectively, with T(max) of 0.750 ± 0.000, 0.250 ± 0.000, 0.291 ± 0.102, and 0.333 ± 0.129 h. Moreover, at a given dose, withanoside V, withanolide B, and withanone were detected in plasma; however, the concentration of these constituents was found below LLOQ. Thus, these four major withanoside and withanolides were quantified in plasma supported by ex vivo permeation data exhibiting a time-dependent absorption of withanosides and withanolides across the intestinal barrier. These composite findings provide insights to design a clinical trial of WSE as a potent nutraceutical.
format Online
Article
Text
id pubmed-8912008
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89120082022-03-11 Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) Modi, Siddharth J. Tiwari, Anshuly Ghule, Chetana Pawar, Sandeep Saste, Ganesh Jagtap, Shubham Singh, Ruchi Deshmukh, Amol Girme, Aboli Hingorani, Lal Molecules Article Withania somnifera is a traditional Indian herb described under the ‘Rasayana’ class in Ayurveda, which gained immense popularity as a dietary supplement in the USA, Europe, Asia, and the Indian domestic market. Despite enormous research on the pharmacological effect of withanosides and withanolides, bioanalytical method development and pharmacokinetics remained challenging and unexplored for these constituents due to isomeric and isobaric characteristics. In current research work, molecular descriptors, pharmacokinetic, and toxicity prediction (ADMET) of these constituents were performed using Molinspiration and admetSAR tools. A rapid, selective, and reproducible bioanalytical method was developed and validated for seven withanosides and withanolides as per USFDA/EMA guidelines, further applied to determine pharmacokinetic parameters of Withania somnifera root extract (WSE) constituents in male Sprague Dawley rats at a dose of 500 mg/kg. Additionally, an ex vivo permeability study was carried out to explore the absorption pattern of withanosides and withanolides from the intestinal lumen. In silico, ADMET revealed oral bioavailability of withanosides and withanolides following Lipinski’s rules of five with significant absorption from the gastrointestinal tract and the ability to cross the blood-brain barrier. Upon oral administration of WSE, C(max) was found to be 13.833 ± 3.727, 124.415 ± 64.932, 57.536 ± 7.523, and 7.283 ± 3.341 ng/mL for withanoside IV, withaferin A, 12-Deoxy-withastramonolide, and withanolide A, respectively, with T(max) of 0.750 ± 0.000, 0.250 ± 0.000, 0.291 ± 0.102, and 0.333 ± 0.129 h. Moreover, at a given dose, withanoside V, withanolide B, and withanone were detected in plasma; however, the concentration of these constituents was found below LLOQ. Thus, these four major withanoside and withanolides were quantified in plasma supported by ex vivo permeation data exhibiting a time-dependent absorption of withanosides and withanolides across the intestinal barrier. These composite findings provide insights to design a clinical trial of WSE as a potent nutraceutical. MDPI 2022-02-22 /pmc/articles/PMC8912008/ /pubmed/35268576 http://dx.doi.org/10.3390/molecules27051476 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Modi, Siddharth J.
Tiwari, Anshuly
Ghule, Chetana
Pawar, Sandeep
Saste, Ganesh
Jagtap, Shubham
Singh, Ruchi
Deshmukh, Amol
Girme, Aboli
Hingorani, Lal
Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title_full Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title_fullStr Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title_full_unstemmed Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title_short Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
title_sort pharmacokinetic study of withanosides and withanolides from withania somnifera using ultra-high performance liquid chromatography-tandem mass spectrometry (uhplc-ms/ms)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912008/
https://www.ncbi.nlm.nih.gov/pubmed/35268576
http://dx.doi.org/10.3390/molecules27051476
work_keys_str_mv AT modisiddharthj pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT tiwarianshuly pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT ghulechetana pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT pawarsandeep pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT sasteganesh pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT jagtapshubham pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT singhruchi pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT deshmukhamol pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT girmeaboli pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms
AT hingoranilal pharmacokineticstudyofwithanosidesandwithanolidesfromwithaniasomniferausingultrahighperformanceliquidchromatographytandemmassspectrometryuhplcmsms